Request for Information-Pandemic and All-Hazards Preparedness and Advancing Innovation Act Section 209; Extension of Comment Period, 19950 [2020-07442]
Download as PDF
<![CDATA[
19950
Federal Register / Vol. 85, No. 69 / Thursday, April 9, 2020 / Notices
organizations that have novice level
experience with federal grants. The
purpose of the SEDS–GO FOA is to
provide financial assistance to tribes
and Native American organizations with
limited capacity, staff, and resources to
compete for federal funding. The
funding is to be used to enhance their
internal capacity and infrastructure to
better serve their members or their
communities. Awards made under the
FOA will have either a 12-, 24-, or 36month project period with an award
ceiling of $200,000, per budget period.
Although it is not required to have a 3year project, the funding opportunity
will allow the flexibility for 1 year of
planning and 2 years of project
implementation. ANA is interested in
funding eligible entities that have
limited experience in managing federal
grants due to their limited ability to
prepare grant applications, administer
projects, evaluate results, or have
limited financial management capacity.
Bonus points will be provided during
the objective review process for
applicants that have never received an
ANA grant award. The SEDS–GO FOA
will request potential applicants to
submit a Letter of Intent within 30 days
of its publication, but this is not
mandatory. The application submission
deadline will be 60 days from the date
the SEDS–GO FOA is published.
Applicants will identify up to two
organizational challenges that will be
addressed within the following program
areas of interest: Staff Development;
Governance; Effective Grants
Management; Strategic/Community
Planning; Financial Management
Systems; Use of Technology; Ability to
Track and Manage Data; and
Partnerships. The ANA Project
Framework will not be applicable to
SEDS–GO FOA. Applicants will identify
up to two targeted challenges within the
Program Areas of Interest; a Project
Goal; Objectives that are Specific,
Measurable, Achievable, Relevant, and
Time-Bound (SMART); and an Indicator
of change.
ANA proposes the following
Evaluation criteria scores for the SEDS–
GO FY 2020:
khammond on DSKJM1Z7X2PROD with NOTICES
Evaluation criteria
Approach, including Objectives
Organizational Capacity ..........
Budget and Budget Justification.
Bonus Points ...........................
Maximum
point
values
70 points.
15 points.
15 points.
16:28 Apr 08, 2020
Jkt 250001
Elizabeth Leo,
Senior Grants Policy Specialist, Office of
Administration, Administration for Children
and Families.
[FR Doc. 2020–07488 Filed 4–8–20; 8:45 am]
BILLING CODE 4184–34–P
DEPARTMENT OF HEALTH OF HUMAN
SERVICES
Request for Information—Pandemic
and All-Hazards Preparedness and
Advancing Innovation Act Section 209;
Extension of Comment Period
Office of Infectious Disease and
HIV/AIDS Policy, Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
AGENCY:
ACTION:
Notice; extension of comment
period.
The Office of the Assistant
Secretary for Health published a
document in the Federal Register of
March 23, 2020 requesting public
comment related to Section 209 of the
Pandemic and All-Hazards
Preparedness and Advancing Innovation
Act. Due to requests of an extension to
the public comment period, this
document is announcing an extension.
SUMMARY:
To be assured consideration,
comments must be received at the
address provided below no later than
midnight Eastern Standard Time (EST)
on June 21, 2020.
DATES:
5 points.
Bonus points will only be awarded if
the applicant organization has never
received an ANA grant award. Bonus
VerDate Sep<11>2014
points will not be awarded in a range—
the application will either receive 0 or
5 points.
All Administrative Policies included
in ANA’s other FY 2020 FOAs will be
applicable to the SEDS–GO FOA.
The following statements are
applicable to the ANA Commissioner’s
discretion as part of the ANA internal
review process for the selection of
applications submitted in response to
the SEDS–GO FOA:
In exercising discretion in award
selection, the Commissioner may choose
not to fund a project if ANA has
information outside the application that
contradicts the justification for the need
for the project. The Commissioner may
choose not to fund any proposed project
that is outside the scope of the listed
program areas of interest. In addition,
the Commissioner may choose not to
fund a project from an applicant that
has received more than two ANA grant
awards within the last 10 years.
Statutory Authority: Section 814 of
the Native American Programs Act of
1974 (NAPA), as amended.
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
FOR FURTHER INFORMATION CONTACT:
Mr.
James Berger, (202) 795–7608;
ACBTSA@hhs.gov.
Dated: April 3, 2020.
James J. Berger,
Senior Advisor for Blood and Tissue Policy,
Office of the Assistant Secretary for Health.
[FR Doc. 2020–07442 Filed 4–8–20; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Tick-Borne Disease
Working Group
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As required by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that the Tick-Borne Disease Working
Group (TBDWG) will hold a meeting.
The meeting will be open to the public.
For this meeting, the TBDWG will
review the work of the Public Comment
and Federal Inventory Subcommittees
and the chapters being developed for
the 2020 report to Congress on federal
tick-borne activities and research.
DATES: The meeting will be held online
via webcast on April 27, 2020, from 9:00
a.m. to 12:30 p.m. ET (times are
tentative and subject to change). The
confirmed times and agenda items for
the meeting will be posted on the
TBDWG web page at https://
www.hhs.gov/ash/advisory-committees/
tickbornedisease/meetings/2020-4-27/
index.html when this information
becomes available.
FOR FURTHER INFORMATION CONTACT:
James Berger, Designated Federal Officer
for the TBDWG; Office of Infectious
Disease and HIV/AIDS Policy, Office of
the Assistant Secretary for Health,
Department of Health and Human
Services, Mary E Switzer Building, 330
C Street SW, Suite L600, Washington,
DC 20024. Email: tickbornedisease@
hhs.gov; Phone: 202–795–7608.
SUPPLEMENTARY INFORMATION: Please
register for the virtual meeting at
https://kauffmaninc.adobeconnect.com/
tbdwg_apr2020/event/event_info.html.
After registering, you will receive an
email confirmation with a personalized
link to access the webcast on April 27.
The public will have an opportunity
to present their views to the TBDWG
orally during the meeting’s public
comment session or by submitting a
SUMMARY:
E:\FR\FM\09APN1.SGM
09APN1
]]>Agencies
[Federal Register Volume 85, Number 69 (Thursday, April 9, 2020)]
[Notices]
[Page 19950]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-07442]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH OF HUMAN SERVICES
Request for Information--Pandemic and All-Hazards Preparedness
and Advancing Innovation Act Section 209; Extension of Comment Period
AGENCY: Office of Infectious Disease and HIV/AIDS Policy, Office of the
Assistant Secretary for Health, Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice; extension of comment period.
-----------------------------------------------------------------------
SUMMARY: The Office of the Assistant Secretary for Health published a
document in the Federal Register of March 23, 2020 requesting public
comment related to Section 209 of the Pandemic and All-Hazards
Preparedness and Advancing Innovation Act. Due to requests of an
extension to the public comment period, this document is announcing an
extension.
DATES: To be assured consideration, comments must be received at the
address provided below no later than midnight Eastern Standard Time
(EST) on June 21, 2020.
FOR FURTHER INFORMATION CONTACT: Mr. James Berger, (202) 795-7608;
[email protected].
Dated: April 3, 2020.
James J. Berger,
Senior Advisor for Blood and Tissue Policy, Office of the Assistant
Secretary for Health.
[FR Doc. 2020-07442 Filed 4-8-20; 8:45 am]
BILLING CODE 4150-28-P
